The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

Simple item page
dc.contributor.authorBasu, Sandip
dc.contributor.authorOstwal, V.
dc.date.accessioned2017-03-09T09:41:48Z
dc.date.available2017-03-09T09:41:48Z
dc.date.issued2016
dc.description.divisionRMCen
dc.format.extent3356 bytes
dc.format.mimetypetext/html
dc.identifier.sourceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016. Vol. 43 (13): pp. 2453-2455en
dc.identifier.urihttp://hdl.handle.net/123456789/14153
dc.language.isoenen
dc.subjectNeuroendocrine tumoren
dc.subjectPeptide receptor radionuclide therapyen
dc.subject68Ga-DOTATATEen
dc.subjectFDG-PET/CTen
dc.subjectChemotherapyen
dc.subject177Lu-DOTATATEen
dc.titleThe case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenariosen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0843.htm
Size:
3.28 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2016